Fallon Lin

1.4k total citations
8 papers, 512 citations indexed

About

Fallon Lin is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Fallon Lin has authored 8 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Fallon Lin's work include Cancer, Hypoxia, and Metabolism (3 papers), Glioma Diagnosis and Treatment (3 papers) and Mitochondrial Function and Pathology (2 papers). Fallon Lin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Glioma Diagnosis and Treatment (3 papers) and Mitochondrial Function and Pathology (2 papers). Fallon Lin collaborates with scholars based in United States, Switzerland and Germany. Fallon Lin's co-authors include Raymond Pagliarini, Alexandra Grassian, Hong Yin, Joseph D. Growney, Minying Pu, Anne N. Murphy, Seth J. Parker, Matthew G. Vander Heiden, Erika D. Handly and Kelly L. Slocum and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Fallon Lin

8 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fallon Lin United States 7 377 261 133 81 65 8 512
Minying Pu United States 5 335 0.9× 227 0.9× 111 0.8× 60 0.7× 17 0.3× 9 452
Meghan J. Seltzer United States 2 297 0.8× 329 1.3× 164 1.2× 56 0.7× 28 0.4× 2 459
Virginie Clément‐Schatlo Switzerland 5 388 1.0× 308 1.2× 75 0.6× 121 1.5× 26 0.4× 6 545
Soumen Kahali United States 8 373 1.0× 157 0.6× 111 0.8× 92 1.1× 48 0.7× 9 539
Jacqueline Sayyah United States 9 368 1.0× 78 0.3× 67 0.5× 178 2.2× 47 0.7× 11 534
Lillian Sams United States 4 298 0.8× 64 0.2× 101 0.8× 115 1.4× 56 0.9× 7 434
Guangning Yan China 11 330 0.9× 182 0.7× 54 0.4× 175 2.2× 84 1.3× 14 507
Madlaina Breuleux Switzerland 8 323 0.9× 66 0.3× 50 0.4× 154 1.9× 79 1.2× 13 486
Ella L. Kim Germany 10 175 0.5× 126 0.5× 137 1.0× 96 1.2× 54 0.8× 19 368
Catherine A. Gallo United States 7 403 1.1× 253 1.0× 33 0.2× 68 0.8× 36 0.6× 9 588

Countries citing papers authored by Fallon Lin

Since Specialization
Citations

This map shows the geographic impact of Fallon Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fallon Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fallon Lin more than expected).

Fields of papers citing papers by Fallon Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fallon Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fallon Lin. The network helps show where Fallon Lin may publish in the future.

Co-authorship network of co-authors of Fallon Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fallon Lin. A scholar is included among the top collaborators of Fallon Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fallon Lin. Fallon Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ye, Ling F., Eduard Reznik, Joshua M. Korn, et al.. (2020). Patient-derived glioblastoma cultures as a tool for small-molecule drug discovery. Oncotarget. 11(4). 443–451. 15 indexed citations
2.
Grassian, Alexandra, Seth J. Parker, Shawn M. Davidson, et al.. (2014). IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism. Cancer Research. 74(12). 3317–3331. 211 indexed citations
3.
Pop, Marius S., Nicolas Stransky, Colin W. Garvie, et al.. (2014). A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein. Molecular Cancer Therapeutics. 13(6). 1492–1502. 49 indexed citations
4.
Grassian, Alexandra, Seth J. Parker, Ajit S. Divakaruni, et al.. (2014). IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism. DSpace@MIT (Massachusetts Institute of Technology). 83 indexed citations
5.
Mounir, Zineb, Fallon Lin, Joshua M. Korn, et al.. (2014). TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation. Oncogene. 34(29). 3815–3825. 46 indexed citations
6.
Grassian, Alexandra, Seth J. Parker, Shawn M. Davidson, et al.. (2014). Abstract LB-139: IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Research. 74(19_Supplement). LB–139. 2 indexed citations
7.
Grassian, Alexandra, Fallon Lin, Rosemary Barrett, et al.. (2012). Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT). Journal of Biological Chemistry. 287(50). 42180–42194. 83 indexed citations
8.
Avers, Charlotte J., Fallon Lin, & Cynthia R. Pfeffer. (1965). HISTOCHEMICAL STUDIES OF MITOCHONDRIAL VARIATION DURING AEROBIC GROWTH OF RESPIRATION-NORMAL BAKER'S YEAST. Journal of Histochemistry & Cytochemistry. 13(5). 344–349. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026